Skip to main content
logo
Iterum Therapeutics plc (ITRM)
NASDAQ: ITRM · Real-Time Price · USD
0.1655
-0.0018 (-1.08%)
At close: Mar 6, 2026, 4:00 PM EST
0.1700
+0.0045 (2.72%)
After-hours: Mar 6, 2026, 5:59 PM EST

Iterum Therapeutics Revenue

Iterum Therapeutics had revenue of $390.00K in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to $390.00K.

Revenue (ttm)
$390.00K
Revenue Growth
n/a
P/S Ratio
22.66
Revenue / Employee
$43,333
Employees
9
Market Cap
8.74M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024---
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Bolt Biotherapeutics5.20M
CollPlant Biotechnologies2.48M
SeaStar Medical Holding881.00K
Cardio Diagnostics Holdings15.78K
Pulmatrix3.00K
Ernexa Therapeutics1,000.00
Revenue Rankings

ITRM News

More News